普米克令舒联合特布他林雾化吸入对小儿喘息性支气管肺炎的疗效观察

Observation on curative effect of pulmicort respules combined with terbutaline inhalation on pediatric asthmatic bronchial pneumonia

目的探讨普米克令舒联合特布他林雾化吸入对小儿喘息性支气管肺炎的治疗效果。方法选择我院2016年2月~2017年2月收治的50例喘息性支气管肺炎患儿为观察对象,将患儿随机分为对照组和观察组两组,各25例。对照组患儿使用常规治疗,观察组患儿使用普米克令舒联合特布他林雾化吸入治疗,对比两组患儿的临床治疗效果。结果观察组患儿的体征消退、症状消退及住院时间均比对照组短,差异具有统计学意义(P<0.05);观察组患儿的治疗有效率为96.0%高于对照组的72.0%,差异具有统计学意义(P<0.05);治疗之后,观察组患儿的肺功能指标改善情况优于对照组,差异具有统计学意义(P<0.05)。结论使用普米克令舒联合特布他林雾化吸入在治疗小儿喘息性支气管肺炎中具有良好的效果,能够使患儿快速消除症状,并且缩短患儿的住院时间,提高患儿的肺功能,值得临床推广使用。

Objective To study the therapeutic effect of pulmicort respules combined with terbutaline inhalation on pediatric asthmatic bronchial pneumonia. Methods 50 children with asthmatic bronchial pneumonia who were admitted in our hospital from February 2016 to February 2017 were selected as observation objects. The children were randomly divided into two groups including control group and observation group, with 25 cases in each group. The control group was treated with routine treatment. The observation group was treated with pulmicort combined with terbutaline inhalation. The clinical efficacy between the two groups of children was compared. Results The subsiding time of signs and symptoms, and length of hospital stay in the observation group were shorter than those in the control group. The difference was statistically significant（P〈0.05）.The treatment effective rate in the observation group was 96.0%, higher than that in the control group（72.0%）.The difference of the data was statistically significant（P〈0.05）. After treatment, the improvement of the lung function index in the observation group was better than that in the control group, and the difference was statistically significant（P〈0.05）. Conclusion The use of pulmicort combined with terbutaline inhalation has a good effect in the treatment of children with asthmatic bronchial pneumonia, which can quickly eliminate symptoms in children,and shorten the hospitalization time of children, improve children＇s lung function, and it is worthy of clinical use.